SFX by Ex Libris Inc.

Title:	Non-disjunction of chromosome 13
Source:	Human Molecular Genetics [0964-6906] Bugge, M yr:2007

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wright, D. "A unified approach to risk assessment for fetal aneuploidies." Ultrasound in obstetrics & gynecology 45.1 (2014): 48-54.
description	2.	Jacobs, P A. "Trisomy 13 ascertained in a survey of spontaneous abortions." Journal of medical genetics 24.12 (1987): 721-4.
description	3.	Li, R. "Yeast: a simple model system to study complex phenomena of aneuploidy." FEMS microbiology reviews 38.2 (2014): 201-12.
description	4.	O Donoghue, K. "The natural history of pregnancies with a diagnosis of Trisomy 18 or Trisomy 13; a retrospective case series." BMC Pregnancy and Childbirth 13.1 (2013): 209-209.
description	5.	Gowen, J W. "MUTATION, CHROMOSOME NON-DISJUNCTION AND THE GENE." Science 68.1757 (1928): 211-2.
description	6.	Zen, Giorgio A. "Trisomy 18: review of the clinical, etiologic, prognostic, and ethical aspects." Rev Paul Pediatr 31.1 (2013): 111-120.
description	7.	Lakovschek, Ioana C. "Natural outcome of trisomy 13, trisomy 18, and triploidy after prenatal diagnosis." American journal of medical genetics. Part A 155A.11 (2011): 2626-2633.
description	8.	Irving, C. "Changes in fetal prevalence and outcome for trisomies 13 and 18: a population-based study over 23 years." Journal of Maternal - Fetal & Neonatal Medicine 24.1 (2010): 137-41.
description	9.	Bruns, Deborah A. "Neonatal experiences of newborns with full trisomy 18." Advances in neonatal care 10.1 (2010): 25-31.
description	10.	Hassold, T. "Nondisjunction of human acrocentric chromosomes: studies of 432 trisomic fetuses and liveborns." Human genetics 94.4 (1994): 411-7.
description	11.	Haarer, B. "Actin Dosage Lethality Screening in Yeast Mediated by Selective Ploidy Ablation Reveals Links to Urmylation/Wobble Codon Recognition and Chromosome Stability." G3 3.3 (2013): 553-561.
description	12.	Jelliffe Pawlowski, L. "Risk of critical congenital heart defects by nuchal translucency norms." American journal of obstetrics and gynecology 212.4 (2014): 518-10.
description	13.	Rao, S. "Socio-demographic and other risk factors of pre eclampsia at a tertiary care hospital, karnataka: case control study." Journal of clinical and diagnostic research 8.9 (2014): -4.
description	14.	Quezada, Maria S. "Screening for trisomies 21, 18 and 13 cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks." Ultrasound in obstetrics & gynecology 45.1 (2014): 36-41.
description	15.	Walker, Brandon S. "A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome." Prenatal diagnosis 35.5 (2014): 440-446.
description	16.	Wu, J. "Trends in maternal age distribution and the live birth prevalence of Down’s syndrome in England and Wales: 1938–2010." European journal of human genetics 21.9 (2013): 943-947.
description	17.	Höcker, B. "Design of proteins from smaller fragmentsâlearning from evolution." Current opinion in structural biology 27C.1 (2014): 56-62.
description	18.	Guaragnella, N. "The expanding role of yeast in cancer research and diagnosis: insights into the function of the oncosuppressors p53 and BRCA1/2." FEMS yeast research 14.1 (2013): 2-16.
description	19.	Johnson, J. "First trimester Down syndrome screening using additional serum markers with and without nuchal translucency and cell free DNA." Prenatal diagnosis 33.11 (2013): 1-6.
description	20.	GOWEN, JW. "VIABILITY OF DROSOPHILA-MELANOGASTER EXPOSED TO X-RAY IRRADIATION." Genetics 1952. 586-587.